BLA for AndexXa refiled by Portola

05:15 EDT 7 Aug 2017 | SmartBrief

Portola Pharmaceuticals has refiled its biologics license application for AndexXa, or andexanet alfa, with inclusion of addit -More

Original Article: BLA for AndexXa refiled by Portola


More From BioPortfolio on "BLA for AndexXa refiled by Portola"

Quick Search

Relevant Topics

The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...